George Coukos

Affiliated with

Research Area

Biography

George Coukos has not added Biography.
If you are George Coukos and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 4	2019

Other Publications

Article	Year
Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapy. Oncoimmunology\| PubMed ID: 27467909	2016
TIE-2 and VEGFR kinase activities drive immunosuppressive function of TIE-2-expressing monocytes in human breast tumors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23649001	2013
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23838316	2013
Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer. International journal of nanomedicine\| PubMed ID: 24790428	2014
Overexpression of SMARCE1 is associated with CD8+ T-cell infiltration in early stage ovarian cancer. The international journal of biochemistry & cell biology\| PubMed ID: 24880093	2014
Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer. Oncotarget\| PubMed ID: 25051365	2014
T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression. Cancer immunology research\| PubMed ID: 25358763	2015
Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy. Critical reviews in biotechnology\| PubMed ID: 25394539	2016
Targeting the tumor vasculature to enhance T cell activity. Current opinion in immunology\| PubMed ID: 25665467	2015
The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 25712684	2015
Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis? Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 25753438	2015
Angiogenic activity of breast cancer patients' monocytes reverted by combined use of systems modeling and experimental approaches. PLoS computational biology\| PubMed ID: 25768678	2015
Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells. Journal of nanobiotechnology\| PubMed ID: 25880772	2015
Personalized approaches to active immunotherapy in cancer. Biochimica et biophysica acta\| PubMed ID: 26241169	2016
Whole Tumor Antigen Vaccines: Where Are We? Vaccines\| PubMed ID: 26343191	2015
Erratum to: Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells. Journal of nanobiotechnology\| PubMed ID: 26407625	2015
Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival. BioMed research international\| PubMed ID: 26448945	2015
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer cell\| PubMed ID: 26461095	2015
Targeting Programmed Cell Death 1 in Ovarian Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 26503205	2015
TCR-engineered T cells to treat tumors: Seeing but not touching? Seminars in immunology\| PubMed ID: 26997556	2016
TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer. Oncoimmunology\| PubMed ID: 27057438	2016
The Human Vaccines Project: A roadmap for cancer vaccine development. Science translational medicine\| PubMed ID: 27075624	2016
Mass spectrometry-based antigen discovery for cancer immunotherapy. Current opinion in immunology\| PubMed ID: 27155075	2016
1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2). Bioorganic & medicinal chemistry letters\| PubMed ID: 27469130	2016
Neoantigen-based cancer immunotherapy. Annals of translational medicine\| PubMed ID: 27563649	2016
Radiotherapy combination opportunities leveraging immunity for the next oncology practice. CA: a cancer journal for clinicians\| PubMed ID: 27570942	2017
Combine and Conquer: Double CTLA-4 and PD-1 Blockade Combined with Whole Tumor Antigen Vaccine Cooperate to Eradicate Tumors. Cancer research\| PubMed ID: 27909064	2016
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk. Oncoimmunology\| PubMed ID: 28123876	2016
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don't Forget the Fuel. Frontiers in immunology\| PubMed ID: 28421069	2017
TIE-2 expressing monocytes in human cancers. Oncoimmunology\| PubMed ID: 28507810	2017
and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes. The Journal of biological chemistry\| PubMed ID: 28536262	2017
The T-Cell Receptor Can Bind to the Peptide-Bound Major Histocompatibility Complex and Uncomplexed β-Microglobulin through Distinct Binding Sites. Biochemistry\| PubMed ID: 28671821	2017
Identifying biological mechanisms for favorable cancer prognosis using non-hypothesis-driven iterative survival analysis. NPJ systems biology and applications\| PubMed ID: 28725481	2016
Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity. PLoS computational biology\| PubMed ID: 28832583	2017
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis. Nature communications\| PubMed ID: 28928446	2017
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy. Oncoimmunology\| PubMed ID: 28932632	2017
'Hotspots' of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization. Frontiers in immunology\| PubMed ID: 29104575	2017
High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome. Molecular & cellular proteomics : MCP\| PubMed ID: 29242379	2018
Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 29304474	2018
Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy. Cancer immunology, immunotherapy : CII\| PubMed ID: 29313073	2018
Sensitive and frequent identification of high avidity neo-epitope specific CD8 T cells in immunotherapy-naive ovarian cancer. Nature communications\| PubMed ID: 29545564	2018
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade. Science translational medicine\| PubMed ID: 29643229	2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer. Science translational medicine\| PubMed ID: 29643231	2018
The C-terminal extension landscape of naturally presented HLA-I ligands. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 29712860	2018
Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis\| PubMed ID: 29766399	2018
Label-Free Optofluidic Nanobiosensor Enables Real-Time Analysis of Single-Cell Cytokine Secretion. Small (Weinheim an der Bergstrasse, Germany)\| PubMed ID: 29806234	2018
CART cells are prone to Fas- and DR5-mediated cell death. Journal for immunotherapy of cancer\| PubMed ID: 30005714	2018
Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome. Molecular & cellular proteomics : MCP\| PubMed ID: 30171158	2018
Correction to: CART cells are prone to Fas- and DR5-mediated cell death. Journal for immunotherapy of cancer\| PubMed ID: 30253808	2018
Two-Dimensional Label-Free Affinity Analysis of Tumor-Specific CD8 T Cells with a Biomimetic Plasmonic Sensor. ACS sensors\| PubMed ID: 30339020	2018
The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 30429286	2018
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy. Cancer immunology, immunotherapy : CII\| PubMed ID: 30564889	2019
A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy. Journal for immunotherapy of cancer\| PubMed ID: 30587227	2018
Safety and Tolerability of Adoptive Cell Therapy in Cancer. Drug safety\| PubMed ID: 30649750	2019
Tumour-reactive T cell subsets in the microenvironment of ovarian cancer. British journal of cancer\| PubMed ID: 30718808	2019
Tumor Landscapes: β-Catenin Drives Immune Desertification. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 30837277	2019
The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance. Cell stem cell\| PubMed ID: 30849366	2019
Computational KIR copy number discovery reveals interaction between inhibitory receptor burden and survival. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing\| PubMed ID: 30864318	2019
Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancer. British journal of cancer\| PubMed ID: 30890776	2019
Going Beyond the Sequences: TCR Binding Patterns at the Service of Cancer Detection. Cancer research\| PubMed ID: 30936076	2019
High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T Cells. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 31015344	2019
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer cell\| PubMed ID: 31185212	2019
Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection. JCI insight\| PubMed ID: 31219806	2019
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function. Frontiers in immunology\| PubMed ID: 31244820	2019
Rational combinations of immunotherapy with radiotherapy in ovarian cancer. The Lancet. Oncology\| PubMed ID: 31364594	2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adeno... Frontiers in immunology\| PubMed ID: 31440238	2019
Integrating SpyCatcher/SpyTag covalent fusion technology into phage display workflows for rapid antibody discovery. Scientific reports\| PubMed ID: 31492910	2019
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8 T cells. Journal for immunotherapy of cancer\| PubMed ID: 31601268	2019
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes. Nature biotechnology\| PubMed ID: 31611696	2019
CD8 Binding of MHC-Peptide Complexes in cis or trans Regulates CD8 T-cell Responses. Journal of molecular biology\| PubMed ID: 31704286	2019
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. Journal for immunotherapy of cancer\| PubMed ID: 31735170	2019
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian ser... Journal of translational medicine\| PubMed ID: 31771601	2019
Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGFβ. EMBO molecular medicine\| PubMed ID: 31793740	2019
Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands. Frontiers in immunology\| PubMed ID: 31824508	2019
Mass spectrometry based immunopeptidomics leads to robust predictions of phosphorylated HLA class I ligands. Molecular & cellular proteomics : MCP\| PubMed ID: 31848261	2019